Core Viewpoint - Guangzhou Pubang Garden Co., Ltd. plans to use up to RMB 800 million of its own funds to invest in financial products, with a rolling usage period of 12 months from the board's approval date [1][4]. Group 1: Financial Product Investment - The company has approved the purchase of various financial products, including a single asset management plan from CITIC Securities with an investment of RMB 40 million, which has an annualized return of 2.5% [1]. - Other investments include RMB 30 million in a closed fixed-income financial product from Huizhong Wealth with an annualized return of 2.25%, and RMB 30 million in a dual-debt strategy from Bank of China with an annualized return of 2.4% to 3.4% [1]. - The company also plans to invest RMB 20 million in a private asset management plan from Haitong Securities, which has a minimum holding period of 180 days [1]. Group 2: Current Financial Product Status - As of the announcement date, the company and its subsidiaries have a total of RMB 555.938 million in outstanding financial products [4]. - The investment in financial products is within the authorized limits set by the board and will not affect the company's daily operational cash flow or main business activities [3][4]. Group 3: Risk Management - The company will conduct prudent evaluations of the financial products and ensure that investments are made in products with good liquidity and high safety, with risk levels not exceeding R3 [3]. - Independent directors will oversee the usage of funds, and the company will disclose the purchase and profit/loss status of financial products in regular reports as per the regulations of the Shenzhen Stock Exchange [3].

证券代码：002663 证券简称：普邦股份 公告编号：2025-046 广州普邦园林股份有限公司 关于使用自有资金购买理财产品的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚假记载、误导性陈述或者 重大遗漏承担责任。 广州普邦园林股份有限公司（以下简称"普邦股份"或"公司"）于 2025 年 4 月 14 日召 开第五届董事会第二十五次会议和第五届监事会第十九次会议，审议通过了《关于使用自有 资金购买理财产品的议案》，同意公司及子公司使用不超过人民币 8 亿元自有资金择机购买理 财产品，在上述额度范围内，资金可以滚动使用，使用期限自董事会审议通过之日起 12 个月 内，并授权公司经营管理层负责具体组织实施。具体内容详见 2025 年 4 月 16 日披露于《中 国证券报》《证券时报》及巨潮资讯网（http://www.cninfo.com.cn）的《关于使用自有资金购买 理财产品的公告》（公告编号：2025-016）。 （3）相关工作人员的操作风险。 2、风险控制措施 （1）公司及子公司将按照相关规定严格控制风险，对理财产品进行审慎评估，经董事会 审议通过的额度内资金只能购买流动 ...

Group 1 - Jiejia Weichuang expects a net profit of 1.7 billion to 1.96 billion yuan for the first half of 2025, representing a year-on-year increase of 38.65% to 59.85% [1] - Micron Biotech's CS231295 clinical trial application has been approved by the FDA for treating advanced solid tumors [1] - Sinopec anticipates a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, a decrease of 39.5% to 43.7% year-on-year [2] Group 2 - High Energy Environment has obtained a loan commitment letter from a financial institution for share repurchase [2] - Electric Power Investment Energy received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inadequate disclosure in its semi-annual report [3] - Zhejiang University Net New won a bid for an intelligent engineering project worth 94.2712 million yuan [5] Group 3 - Daodaoquan reported a net profit of 181 million yuan for the first half of 2025, a year-on-year increase of 563.15% [8] - New Light Optoelectronics expects a net loss of 19 million to 23 million yuan for the first half of 2025 [9] - Aihua Pharmaceutical's two probiotic powder registration applications have been accepted [10] Group 4 - Xinhui Electric's subsidiary signed a product sales framework contract for commercial and household robots [11] - Baida Precision Engineering's subsidiary obtained 134,500 square meters of industrial land use rights [12] - Haiyang Technology's chief engineer resigned for personal reasons [13] Group 5 - Tianhe Magnetic Materials received a project filing notice for a 12,000-ton magnetic material deep processing project [22] - Wanlima is the pre-selected unit for a procurement project worth 43.835 million yuan from China Southern Airlines [24] - Yipin Hong's subsidiaries obtained two drug registration certificates [25] Group 6 - Zhejiang Jiaoke's subsidiary signed new construction projects worth 4.783 billion yuan in the second quarter [27] - Shenglan Co. received approval for issuing convertible bonds [29] - Jimi Technology expects a net profit of 88.6622 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [31] Group 7 - Dingtong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06% [32] - Huaheng Biological is planning to list on the Hong Kong Stock Exchange [34] - Yuntian Lihui submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [36] Group 8 - Nanchip Technology expects a net profit of 108.8 million to 133.1 million yuan for the first half of 2025, a decrease of 35.09% to 47.03% year-on-year [43] - Anglikang's Mesobam injection has received a drug registration certificate [44] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.998% [45]

Core Viewpoint - The legal opinion letter from Beijing Dacheng (Guangzhou) Law Firm confirms the legality of the procedures and qualifications related to the second extraordinary general meeting of shareholders of Guangzhou Pubang Garden Co., Ltd. in 2025, including the convening, attendance, and voting processes [1][2][7]. Group 1: Meeting Procedures - The extraordinary general meeting was proposed and convened by the board of directors, with the proposal approved during the second meeting of the sixth board on July 14, 2025 [2][3]. - The notice and proposal content for the meeting were disclosed through official channels on July 15, 2025 [3]. - The meeting was conducted using a combination of on-site and online voting, with the chairman of the board, Mr. Tu Wenzhe, presiding over the meeting [3][4]. Group 2: Attendance and Voting - All registered shareholders of the limited liability company’s Shenzhen branch had the right to attend the meeting, and they could appoint proxies to participate and vote [4]. - A total of 366 participants, including shareholders and their representatives, attended the meeting, representing 650,903,849 shares, which accounted for the majority of the voting rights [4][5]. - The online voting results indicated that 359 shareholders participated, representing 34,108,655 shares, with a breakdown of 7,184,887 shares from on-site attendance and 26,923,768 shares from online voting [4][5]. Group 3: Proposals and Voting Results - The main proposal for the meeting was to increase the company's business scope and amend the company’s articles of association, which was disclosed in the meeting notice [5][6]. - The voting results showed that the proposal received a total of 660,378,838 votes in favor, 17,326,600 votes against, and 122,179 abstentions, leading to the proposal's approval [6][7]. - The legal opinion confirmed that the voting procedures and results were in compliance with relevant laws, regulations, and the company's articles of association [6][7].

Meeting Overview - The meeting was held on July 30, 2025, with voting conducted through both on-site and online platforms [1][2] - A total of 366 shareholders participated, representing 677,827,617 shares, which accounts for 39.3320% of the company's voting shares [1][2] Shareholder Participation - Among the participants, 10 shareholders voted on-site, representing 650,903,849 shares (37.7697% of total voting shares) [1] - 356 shareholders voted online, representing 26,923,768 shares (1.5623% of total voting shares) [1][2] - A total of 359 minority shareholders participated, representing 34,108,655 shares (1.9792% of total voting shares) [1] Proposal Voting Results - Proposal 1, concerning the expansion of the company's business scope and the amendment of the Articles of Association, received 660,378,838 votes in favor, which is 97.4258% of the valid votes cast [2] - Minority shareholders voted 16,659,876 shares in favor, accounting for 48.8435% of the valid votes from minority shareholders [2] - The proposal was passed as it achieved more than two-thirds of the valid votes required for special resolutions [2] Legal Opinion - The meeting was witnessed by lawyers from Beijing Dacheng (Guangzhou) Law Firm, who confirmed that the meeting's procedures complied with legal and regulatory requirements [3]

Core Viewpoint - Pubang Co., Ltd. announced the convening of its second extraordinary general meeting of shareholders in 2025 on July 30, 2025, to review and approve the proposal to expand the company's business scope and amend relevant articles [2] Group 1 - The extraordinary general meeting was held on July 30, 2025 [2] - The meeting's agenda included the proposal to increase the company's business scope [2] - The proposal also involved amendments to the company's articles [2]

Group 1 - The core point of the article is that Pubang Co., Ltd. (002663) announced the signing of 176 new contracts in the second quarter of 2025, with a total amount of 385 million yuan [1] Group 2 - The total value of the new contracts signed in the second quarter of 2025 is 385 million yuan [1] - The number of new contracts signed during this period is 176 [1]

普邦股份（002663）(002663.SZ)披露2025年第二季度经营情况，公司2025年第二季度合计新签合同176 个，金额达3.85亿元。 ...

智通财经APP讯，普邦股份(002663.SZ)披露2025年第二季度经营情况，公司2025年第二季度合计新签合 同176个，金额达3.85亿元。 ...

证券代码：002663 证券简称：普邦股份 公告编号：2025-045 广州普邦园林股份有限公司 2025 年第二季度经营情况简报 二、重大项目履行情况 2016年11月28日，郑州市中原区高新社会事务中心城市管理部（原郑州高新技术产业开 发区管理委员会市政管理局，以下简称"甲方"）发布"郑州高新区市政绿化PPP项目中标、成 交结果公告"，确认公司和梅州市市政建设集团公司联合体（以下合称"中标人"）为郑州高新 区市政绿化PPP项目（以下简称"项目"）的中标社会资本方。中标人与政府方代表郑州高新智 慧城市运营集团有限公司（原郑州高新市政建设有限公司）于2017年4月10日在郑州市成立了 郑州高新区锦邦建设有限公司（以下简称"项目公司"）。甲方和项目公司于2017年4月19日签 署《郑州高新区市政绿化PPP项目合同》（以下简称"《项目合同》"），项目投资金额为33.20亿 元，业务模式为PPP模式，项目合作期为15年（其中建设期5年、运营期10年）。具体情况详见 公司于2021年7月17日披露的《关于签署<郑州高新区市政绿化PPP项目合同>的补充披露公告》 （公告编号：2021-040）。 本公司及董事会全体成员 ...